Vasa Therapeutics Announces Upcoming Presentations at AHA Scientific Sessions 2022
/PRNewswire/ -- Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no...
Source: prnewswire.com